image
KalVista Pharmaceuticals, Inc. KALV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.49
-3.16 %
$ 462 M
Market Cap
-2.74
P/E
BALANCE SHEET
235 M ASSETS
28.49%
Growth Rates
1Year 28.49%
3Years -4.70%
5Years 14.79%
7Years 31.65%
10Years 37.00%
28.8 M LIABILITIES
29.96%
Growth Rates
1Year 29.96%
3Years 24.82%
5Years 6.14%
7Years 38.04%
10Years -4.10%
207 M EQUITY
28.29%
Growth Rates
1Year 28.29%
3Years -7.04%
5Years 16.39%
7Years 30.93%
10Years 23.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition KalVista Pharmaceuticals, Inc.
image
Current Assets 226 M
Cash & Short-Term Investments 210 M
Receivables 10.9 M
Other Current Assets 4.42 M
Non-Current Assets 9.71 M
Long-Term Investments 0
PP&E 9.15 M
Other Non-Current Assets 567 K
Current Liabilities 22.8 M
Accounts Payable 9.11 M
Short-Term Debt 1.3 M
Other Current Liabilities 12.4 M
Non-Current Liabilities 6.02 M
Long-Term Debt 6.02 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 31.8 56.2 30.7 50.6 15.8 32.0 51.1 30.9 21.8 3.9 9.8 8.2
Short Term Investments 178.6 93.1 135.5 198.3 51.9 68.8 0 0 0 0 0 0
Receivables 10.9 16.6 0 10.4 16.5 11.3 6.8 2.5 0.4 0 0 0
Inventory 0 0 2.7 0 0 0 0 0 0 235 0 0
Other Current Assets 4.4 4.3 10.6 3.6 4.5 3.4 1.5 0.7 0.7 0.2 0.1 83 K
Total Current Assets 225.7 172.3 193.6 264.3 88.7 115.5 59.4 34.2 24.7 4.6 9.9 8.3
PP&E 9.1 10.8 10.0 7.5 3.7 2.4 1.8 97 K 74 K 0.2 75 K 84 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0.2 0 0 0
Other Long Term Assets 0.6 0.1 0.2 0.2 0.2 0.2 0.2 0 (0.2) 1.9 0.1 0.1
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0
Total Assets 235.4 183.2 203.9 272.0 92.5 118.1 61.4 34.3 24.7 6.6 10.1 8.5
LIABILITIES
Accounts Payable 9.1 4.8 3.6 2.0 1.7 2.9 1.4 1.2 1.0 1.0 0.5 0.1
Short Term Debt 1.3 1.1 1.0 0.9 0.6 54 K 0.2 0 0 4.4 3.1 2.7
Other Current Liabilities 12.4 9.1 7.0 6.9 5.5 5.6 3.1 1.9 2.2 1.6 0.4 0.2
Total Current Liabilities 22.8 15.0 11.6 9.8 7.7 18.1 23.2 3.0 3.2 7.1 4.0 3.1
Long Term Debt 6.0 7.1 7.2 5.0 1.1 0 58 K 0 0 2.1 0 0
Deferred Tax Income 0 0 0 0 0 0 (10.9) 0 (3.2) 3.3 0 0
Other Liabilities 0 0 0 0 0 0 0 0 56 K 38.2 39.7 33.6
Total Liabilities 28.8 22.2 18.8 14.8 8.8 21.4 34.1 3.0 3.2 50.8 43.8 36.8
EQUITY
Common Stock 42 K 34 K 25 K 24 K 18 K 17 K 11 K 10 K 3 K 1 K 2 K 2 K
Retained Earnings (469.7) (343.1) (250.2) (167.8) (121.6) (92.5) (71.7) (55.9) (37.3) (47.8) (34.4) (28.7)
Other Accumulative Comprehensive Income/Loss (3.5) (3.1) (3.9) (1.4) (1.9) (1.9) (1.1) (2.6) 75 K (0.5) (0.4) (0.4)
Total Equity 206.6 161.0 185.1 257.2 83.8 96.7 27.3 31.3 21.5 (44.2) (33.7) (28.3)
Total Liabilities and Equity 235.4 183.2 203.9 272.0 92.5 118.1 61.4 34.3 24.7 6.6 10.1 8.5
SHARES OUTSTANDING
Common Shares Outstanding 36.8 27.9 24.5 19.1 17.7 15.1 10.3 9.7 4.8 1.2 0.7 0.7